These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 335871)

  • 1. Alkaline phosphatase-positive malignant lymphoma. A subtype of B-cell lymphomas.
    Nanba K; Jaffe ES; Braylan RC; Soban EJ; Berard CW
    Am J Clin Pathol; 1977 Nov; 68(5):535-42. PubMed ID: 335871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of non-Hodgkin's lymphomas using multiple cell markers. Immunologic, morphologic, and cytochemical studies of 72 cases.
    Pinkus GS; Said JW
    Am J Pathol; 1979 Feb; 94(2):349-80. PubMed ID: 311589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alkaline phosphatase-positive B cell lymphomas.
    Abe M; Nozawa Y; Wachi E; Tominaga K; Hojo H; Wakasa H
    Eur J Haematol; 1988 Sep; 41(3):223-9. PubMed ID: 3053240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. alpha-Naphthyl acetate esterase activity--a cytochemical marker for T lymphocytees. Correlation with immunologic studies of normal tissues, lymphocytic leukemias, non-Hodgkin's lymphomas, Hodgkin's disease, and other lymphoproliferative disorders.
    Pinkus GS; Hargreaves HK; McLeod JA; Nadler LM; Rosenthal DS; Said JW
    Am J Pathol; 1979 Oct; 97(1):17-41. PubMed ID: 315166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alkaline phosphatase positive lymphomas: a morphologic, immunologic, and enzymehistochemical study.
    Poppema S; Elema JD; Halie MR
    Cancer; 1981 Mar; 47(6):1303-12. PubMed ID: 6971701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunologic aspects and pathology of the malignant lymphomas.
    Berard CW; Jaffe ES; Braylan RC; Mann RB; Nanba K
    Cancer; 1978 Aug; 42(2 Suppl):911-21. PubMed ID: 356957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alkaline phosphatase positive lymphoma.
    Geerts ML; Burg G; Schmoeckel C; Braun-Falco O
    Dermatologica; 1984; 169(6):342-7. PubMed ID: 6335434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-Hodgkin's lymphomas: an ultrastructural study correlating morphology with immunologic cell type.
    Said JW; Hargreaves HK; Pinkus GS
    Cancer; 1979 Aug; 44(2):504-28. PubMed ID: 383256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunologic surface markers in non-Hodgkin's lymphomas.
    Cossman J; Schnitzer B; Deegan MJ
    Am J Pathol; 1977 Apr; 87(1):19-32. PubMed ID: 322504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunolocalization of the ICE/Ced-3-family protease, CPP32 (Caspase-3), in non-Hodgkin's lymphomas, chronic lymphocytic leukemias, and reactive lymph nodes.
    Krajewski S; Gascoyne RD; Zapata JM; Krajewska M; Kitada S; Chhanabhai M; Horsman D; Berean K; Piro LD; Fugier-Vivier I; Liu YJ; Wang HG; Reed JC
    Blood; 1997 May; 89(10):3817-25. PubMed ID: 9160689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surface phenotyping, histology and the nature of non-Hodgkin lymphoma in 157 patients.
    Habeshaw JA; Catley PF; Stansfeld AG; Brearley RL
    Br J Cancer; 1979 Jul; 40(1):11-34. PubMed ID: 314300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malignant lymphomas as tumours of the immune system.
    Berard CW; Cossman J; Jaffe ES
    Br J Cancer; 1980 Jul; 42(1):1-20. PubMed ID: 7000112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta-glucuronidase activity of lymph node imprints from malignant lymphomas and chronic lymphocytic leukaemia.
    Pangalis GA; Yataganas X; Fessas P
    J Clin Pathol; 1977 Sep; 30(9):812-6. PubMed ID: 303244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enzyme histochemical characteristics of non-Hodgkin's lymphomas.
    Harigaya K
    Acta Pathol Jpn; 1977 May; 27(3):345-58. PubMed ID: 144406
    [No Abstract]   [Full Text] [Related]  

  • 15. Terminal deoxynucleotidyl transferase activity in malignant lymphomas.
    Donlon JA; Jaffe ES; Braylan RC
    N Engl J Med; 1977 Sep; 297(9):461-4. PubMed ID: 301987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of lymphocytic surface markers and histology in adult non-Hodgkin's lymphoma.
    Bloomfield CD; Kersey JH; Brunning RD; Gajl-Peczalska KJ
    Cancer Treat Rep; 1977 Sep; 61(6):963-70. PubMed ID: 332359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphocytic beta-glucuronidase in the lymphoproliferative syndromes.
    Zittoun R; Cadiou M; Dao C; Blanc JM; Bousser J
    Biomedicine; 1973 Sep; 18(5):515-20. PubMed ID: 4201753
    [No Abstract]   [Full Text] [Related]  

  • 18. [Classiciation of non-Hodgkin's lymphomas of childhood (author's transl)].
    Lennert K
    Klin Padiatr; 1977 Jan; 189(8):7-13. PubMed ID: 320375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malignant lymphoma of true histiocytic (monocyte/macrophage) origin.
    Isaacson P; Wright DH; Jones DB
    Cancer; 1983 Jan; 51(1):80-91. PubMed ID: 6336974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surface markers and functional properties of non-Hodgkin's lymphoma cells in relation to histology.
    Bom-Van Noorloos AA; Splinter TA; van Heerde P; van Beek AA; Melief CJ
    Cancer; 1978 Oct; 42(4):1804-17. PubMed ID: 152144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.